FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy Heparin 2 mL/Lidocaine 2%-10 mL/Sodium Recall

Heparin 2 mL/Lidocaine 2%-10 mL/Sodium Bicarbonate 8

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · Bristol, TN

Risk level
Class II
Reported by FDA
Apr 24, 2019
Recall ID
D-1160-2019
Check your lot numberHow we source this data

Summary

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy recalled Heparin 2 mL/Lidocaine 2%-10 mL/Sodium starting Apr 2, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1160-2019 on Apr 24, 2019. Reason: Lack of sterility assurance. Status: Terminated.

Why it was recalled

Lack of sterility assurance.

Product description

Heparin 2 mL/Lidocaine 2%-10 mL/Sodium Bicarbonate 8.4%-5mL/ Sterile Water 10 mL, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

Lot numbers, UPCs & expiration codes

All Lots

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1160-2019
Classification
Class II
Status
Terminated
Recall initiated
Apr 2, 2019
FDA report date
Apr 24, 2019
Quantity
6 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Original FDA data

Every field from FDA enforcement report D-1160-2019, exactly as published.

Show all FDA fields
City
Bristol
State
TN
Status
Terminated
Country
United States
Event ID
82554
Address
Attn: Cleve Anderson
Address (line 2)
310 Bluff City Hwy
Code information
All Lots
Postal code
37620-4602
Report date
Apr 24, 2019
Product type
Drugs
Recall number
D-1160-2019
Classification
Class II
Recalling firm
Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
Product quantity
6 syringes
Termination date
Sep 24, 2021
Reason for recall
Lack of sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Heparin 2 mL/Lidocaine 2%-10 mL/Sodium Bicarbonate 8.4%-5mL/ Sterile Water 10 mL, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
Distribution pattern
Nationwide
Recall initiation date
Apr 2, 2019
Initial firm notification
Letter
Center classification date
Apr 18, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1160-2019, published Apr 24, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls